 |
|
|
 |
|
 |
Dermatology |
 |
| |
| 19 Oct 2009 | Viewed: 176 | |
|
The National Institutes of Health has announced that it is awarding 15
new grants to further develop and test the Patient Reported Outcomes
Measurement Information System (PROMIS). Managed by the National
Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),
PROMIS aims to revolutionize the way patient reported outcome tools are
selected and employed in clinical research and practice.
PROMIS utilizes advances in computer technology and modern measurement theory to assess outcomes such as pain, fatigue,
and other aspects of quality of life in a standardized manner. An
important goal of the initiative is to develop valid and reliable
clinical instruments that will allow the measurement of
patient-reported symptoms more efficiently and effectively.
"Due to the success of PROMIS and growing interest of various
research and health care communities, the NIH Roadmap mechanism has
allowed an additional four years of funding for this initiative," said
Raynard S. Kington, M.D., Ph.D., deputy director, NIH. "The second
phase of PROMIS will continue to advance the field of patient
self-reporting by conducting large-scale validation studies in a
variety of clinical populations."
"These outcomes have a major impact on quality of life across
a variety of chronic diseases and are often the best way to judge the
value of treatments," said NIAMS director Stephen I. Katz, M.D., Ph.D.
"An important priority during the second funding phase of this
initiative will be to strengthen assessment of patient-reported
outcomes in all relevant population groups, including minorities,
women, underserved individuals, and children."
The PROMIS network will support a comprehensive, integrated
approach to data collection, storage, and management and will consist
of three administrative centers and 12 research sites. The initiative
is designed to be a vital resource for the clinical research community.
According to Josephine P. Briggs, M.D., director of the National Center
for Complementary and Alternative Medicine (NCCAM), "PROMIS holds
potential to provide very valuable standardized measurement tools that
will allow greater comparability of studies, and substantially reduce
the burden on patients participating in research studies."
|
|
| |
| News Source: medical news today |
|
Back
|
|
| |
|
|
|
|
| |
|
|
|
|
Powered By Aeon IT Solutions